<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kuse Y</submitter><funding>Ministry of Education, Culture, Sports, Science and Technology (MEXT)</funding><funding>Japan Agency for Medical Research and Development (AMED)</funding><pagination>2493</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11906828</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Organoids derived from human induced pluripotent stem cells (hiPSC) are potentially applicable for regenerative medicine. However, the applications have been hampered by limited organoid size and function as a consequence of a lack of progenitor expansion. Here, we report the recapitulation of progenitor expansion in hiPSC-liver organoids based on the analysis of mouse development. Visualization of blood perfusion and oxygen levels in mouse embryos reveals a transient hypoxic environment during hepatoblast expansion, despite active blood flow. During this specific stage, the placenta expresses various growth factors. Human and mouse placenta-liver interaction analysis identifies various placenta-derived factors. Among them, IL1α efficiently induces the growth in hiPSC-liver organoids as we</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Placenta-derived factors contribute to human iPSC-liver organoid growth.</pubmed_title><pmcid>PMC11906828</pmcid><funding_grant_id>19K18034</funding_grant_id><funding_grant_id>JP13bm0304002</funding_grant_id><funding_grant_id>22K16440</funding_grant_id><funding_grant_id>JP22bm0304002h0310</funding_grant_id><funding_grant_id>21H04830</funding_grant_id><funding_grant_id>JP23bm1223007</funding_grant_id><pubmed_authors>Matsumoto S</pubmed_authors><pubmed_authors>Kasai T</pubmed_authors><pubmed_authors>Tsuzuki S</pubmed_authors><pubmed_authors>Ueno Y</pubmed_authors><pubmed_authors>Oba T</pubmed_authors><pubmed_authors>Kuse Y</pubmed_authors><pubmed_authors>Furukawa Y</pubmed_authors><pubmed_authors>Tadokoro T</pubmed_authors><pubmed_authors>Carolina E</pubmed_authors><pubmed_authors>Yamabe S</pubmed_authors><pubmed_authors>Taniguchi H</pubmed_authors><pubmed_authors>Tanimizu N</pubmed_authors><pubmed_authors>Yamaguchi K</pubmed_authors><pubmed_authors>Okumura T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Placenta-derived factors contribute to human iPSC-liver organoid growth.</name><description>Organoids derived from human induced pluripotent stem cells (hiPSC) are potentially applicable for regenerative medicine. However, the applications have been hampered by limited organoid size and function as a consequence of a lack of progenitor expansion. Here, we report the recapitulation of progenitor expansion in hiPSC-liver organoids based on the analysis of mouse development. Visualization of blood perfusion and oxygen levels in mouse embryos reveals a transient hypoxic environment during hepatoblast expansion, despite active blood flow. During this specific stage, the placenta expresses various growth factors. Human and mouse placenta-liver interaction analysis identifies various placenta-derived factors. Among them, IL1α efficiently induces the growth in hiPSC-liver organoids as we</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-04-08T19:48:37.734Z</modification><creation>2025-04-05T22:08:05.308Z</creation></dates><accession>S-EPMC11906828</accession><cross_references><pubmed>40082402</pubmed><doi>10.1038/s41467-025-57551-w</doi></cross_references></HashMap>